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Heterochromatin serves important functions, pro-
tecting genome integrity and stabilizing gene expres-
sion programs. Although the Suv39h methyltrans-
ferases (KMTs) are known to ensure pericentric
H3K9me3 methylation, the mechanisms that initiate
and maintain mammalian heterochromatin organiza-
tion remain elusive. We developed a biochemical
assay and used in vivo analyses in mouse embryonic
fibroblasts to identify Prdm3 and Prdm16 as redun-
dant H3K9me1-specific KMTs that direct cyto-
plasmic H3K9me1methylation. The H3K9me1 is con-
verted in the nucleus to H3K9me3 by the Suv39h
enzymes to reinforce heterochromatin. Simulta-
neous depletion of Prdm3 and Prdm16 abrogates
H3K9me1 methylation, prevents Suv39h-dependent
H3K9me3 trimethylation, and derepresses major
satellite transcription. Most strikingly, DNA-FISH
and electron microscopy reveal that combined
impairment of Prdm3 and Prdm16 results in disinte-
gration of heterochromatic foci and disruption of
the nuclear lamina. Our data identify Prdm3 and
Prdm16 as H3K9me1 methyltransferases and
expose a functional framework in which anchoring
to the nuclear periphery helps maintain the integrity
of mammalian heterochromatin.INTRODUCTION
Mammalian heterochromatin has important functions for
genome organization, chromosome segregation, and in stabi-
lizing gene expression programs. In mouse fibroblasts, pericen-948 Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc.tric heterochromatin clusters into distinct heterochromatic foci,
which can be visualized by DAPI-staining of the underlying
A/T-rich satellite repeats. In addition to this characteristic
concentration into heterochromatic foci, a biochemical pathway
for the Suv39h enzymes to induce H3K9me3 and binding of HP1
is a hallmark for mammalian heterochromatin (Bannister et al.,
2001; Lachner et al., 2001; Rea et al., 2000). Loss of the
Suv39h KMTs significantly impairs heterochromatic modification
patterns and results in reduction of H3K9me3 to H3K9me1 but
allows preservation of heterochromatin organization within
DAPI-dense foci (Peters et al., 2003). These data indicate that
other mechanisms, such as H3K9me1, initiate and precede
Suv39h function at pericentric heterochromatin.
Several additional enzymes participate in heterochromatin
formation (e.g., Hdac1, Eset/Setdb1, Suv4-20h, and Dnmt3a/b;
for review see Fodor et al., 2010), and a substochiometric
complex containing Suv39h, Eset, and G9a/Glp1 has been
described (Fritsch et al., 2010). For both Suv39h and Suv4-20h
deficiency, there is conversion to the monomethyl state but not
to the fully unmodified state (Peters et al., 2003; Schotta et al.,
2008). These data expose an important function for histone
monomethylation and suggest two-step pathways for the estab-
lishment of H3K9me3 and H4K20me3 that require pre-existing
H3K9me1 and H4K20me1. Monomethylating KMTs appear to
be essential enzymes because their loss-of-function is embry-
onic lethal and defies cell viability. For example, knockout of
the H4K20 monomethylase Pr-Set7 blocks development of
mouse embryos prior to the eight cell stage (Oda et al., 2009).
Also, loss of Eset results in early embryonic lethality starting at
day E3.5 (Dodge et al., 2004). Importantly, this enzyme can
convert unmodified substrates to a monomethyl state but also
acts progressively toward the generation of H3K9me3 (Loyola
et al., 2009; Wang et al., 2003).
H3K9me1 has been shown to be present in the free pool of
histones in the cytoplasm and nucleus. This is prominent for
H3K9me1 (and H3K9me2) because most of the other histone
methylation marks cannot be detected in nonnucleosomal
histones (Loyola et al., 2006). We used a biochemical assay to
identify enzymes that will convert an unmodified histone peptide
to the H3K9me1 state and be inactive toward a H3K9me1
substrate. This analysis discovered Prdm3 and Prdm16 as
H3K9me1-specific KMTs. The mammalian Prdm/PRDM family
of SET domain enzymes consists of 17 members and is charac-
terized by the combination of a PR-SET domain with a variable
number of Zn-fingers (Fumasoni et al., 2007). It includes impor-
tant regulators for chromatin function (e.g., PRDM2/RIZ and
Prdm9/Meisetz) (Hayashi et al., 2005; Kim et al., 2003) and
transcription-factor-like activities that are involved in cell fate
determination (e.g., Prdm1/Blimp and Prdm14) (Ma et al.,
2011; Ohinata et al., 2005; Yamaji et al., 2008). Prdm3 and
Prdm16 serve important functions in hematopoietic (Aguilo
et al., 2011; Goyama et al., 2008) and neuronal stem cells
(Chuikov et al., 2010) and in adipose tissue differentiation (Seale
et al., 2008) but have also been described as oncoproteins
(Mel1 and Evi1) in translocation-induced leukemia (Mochizuki
et al., 2000; Morishita, 2007; Perkins et al., 1991). Although these
functions for Prdm3 and Prdm16 are well documented, no role
in heterochromatin formation has been evident. This is probably
because their gene function could be redundant, as has often
been the case for mammalian heterochromatin components.
Similar observations have been made for Suv39h1 and Suv39h2
(Peters et al., 2001), Suv4-20h1 and Suv4-20h2 (Schotta
et al., 2008), Dnmt3a and Dnmt3b (Okano et al., 1999), and for
transcription factors (e.g., Pax3 and Pax9) that repress RNA
output from heterochromatic repeat sequences (Karslioglu
et al., 2012).
Based on the biochemical definition of Prdm3 and Prdm16 as
H3K9me1 KMTs, we analyzed their contribution to mammalian
heterochromatin formation by simultaneously depleting Prdm3
and Prdm16 in mouse embryonic fibroblasts. Our data demon-
strate that Prdm3 andPrdm16 initiate heterochromatin formation
by inducing cytoplasmic H3K9me1, which is then converted in
the nucleus by the Suv39h enzymes to H3K9me3. Most notably,
Prdm3 and Prdm16 are also required to maintain the subnuclear
organization of mammalian heterochromatin because their
impaired function dissolves DAPI-dense foci and unstructures
the nuclear lamina. Our work thus discovers Prdm3 and
Prdm16 as H3K9me1-specific enzymes in a sequential pathway
that defines heterochromatic H3K9 methyl marks. In addition, it
exposes a functional framework in which the anchoring to the
nuclear lamina appears as an important mechanism to protect
the integrity of mammalian heterochromatin.
RESULTS
Purification of H3K9me1-Specific Methyltransferases
To develop a biochemical assay that would allow the identifica-
tion of specific H3K9me1 KMTs, we first analyzed the distribu-
tion of H3K9 methylation in different cellular compartments.
For this, histones were acid-extracted from cytoplasmic and
nuclear fractions and subsequently probed with antibodies
directed against unmodified histone H3, H3K9me1, H3K9me2,
and H3K9me3. In HeLa cells all H3K9 methylation states are
present in the nucleus, but in the cytoplasm only H3K9me1and H3K9me2 are detected (Figure 1A), which is in line with
previous reports (Loyola et al., 2006). Although wild-type (WT)
immortalized mouse embryonic fibroblasts (iMEFs) display
the same distribution as human cells, Suv39h double null
(Suv39h dn) iMEFs are depleted for nuclear H3K9me3 (Fig-
ure 1A). This experiment confirmed that H3K9me1 occurs in
the cytoplasm and nucleus of human and mouse cells and
suggests that the responsible enzyme(s) might reside in both
cellular compartments.
We next performed in vitro methyltransferase assays with
cytoplasmic and nuclear extracts of HeLa cells. The radioactive
methyl group of S-adenosylmethionine (SAM) is efficiently trans-
ferred onto recombinant histone H3 in both extracts (Figure 1B).
However, full-length histone H3 as a substrate does not
allow discrimination between different methylation sites or
methylation states. Therefore, we used histone peptides span-
ning the H3K9 position, either unmodified or monomethylated
at lysine 9. A longer H3K9 peptide (amino acid [aa] 1–20) is
again methylated in both extracts independently of its H3K9
methylation status. We next tried a very short peptide containing
aa 6–11 (TARKST-2b), where lysine 9 is the only lysine in this
substrate. These peptides were synthesized as branched
molecules and present two linear aa sequences that are cova-
lently linked by a C-terminal cysteine (so called two-branched,
or 2b, peptides) (Peters et al., 2003). Strong and comparable
enzymatic activities toward the unmodified TARKST-2b, but not
toward the TARK(me1)ST-2b, peptide were observed in both
cytoplasmic and nuclear extracts (Figure 1B).
For the initial purification, we decided to focus on cytoplasmic
fractions because we detected substantial amounts of this
modification in the cytoplasm (Figure 1A) and because
H3K9me1 has been described as a prominent modification of
nonnucleosomal histones (Loyola et al., 2006). To identify
H3K9me1-specific KMT(s), HeLa S100 extracts were subjected
to a series of chromatography columns (detailed purification
scheme in Figure 1C) and the H3K9me1 activity in the eluted
fractions was monitored via radioactive KMT assays by using
the short TARKST-2b and TARK(me1)ST-2b peptides as
substrates (Figure 1E). After the last gel filtration column, odd-
numbered fractions were used in KMT assays (Figure 1E), and
their protein content was visualized on silver-stained SDS gels
(Figure 1D). Fractions 19 through 39 displayed the activity profile
of a specific H3K9 mono-KMT: active on the unmodified, but
inactive on the TARK(me1)ST-2b peptide (Figure 1E). After reso-
lution on a silver-gel, we observed two distinct banding patterns:
in fractions 19–25 there was hardly any bands visible, whereas
fractions 27–39 contained up to 4 prominent bands. To
not exclude any enzymes, we used one representative fraction
of the remaining even-numbered fractions (24 and 30) for in-
solution digests and mass spectrometry (MS)-based protein
identification.
Analysis of sequenced peptides identified 500 proteins
within these two fractions, including 32 proteins with a described
chromatin connection (for a detailed listing see Table S1
available online). Next to DNA replication complexes, nuclear
transport factors, and protein chaperones, there were also
several enzymes such as acetyltransferases/deacetylases
and methyltransferases/demethylases. Most notably, fourCell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc. 949
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Figure 1. Purification of H3K9me1 Enzymes
(A) Western blot analysis of H3K9methylation states in cytoplasmic and nuclear extracts of WT iMEFs, Suv39h dn iMEFs and HeLa cells. Acid-extracted histones
were probed with modification-specific antibodies for unmodified H3, H3K9me1, H3K9me2, and H3K9me3. Antibodies against Gapdh (cytoplasmic) and HP1a
(nuclear) were used as a control.
(B) H3K9me1 KMT activity in cytoplasmic and nuclear extracts of HeLa cells. Extracts were incubated with radioactive SAM and the following H3 substrates:
recombinant H3; H3 (aa 1–20) peptides, unmodified and H3K9me1; H3 (aa 6–11) peptides, unmodified (TARKST-2b) or H3K9me1 (TARK(me1)ST-2b).
Incorporation of the radioactive methyl group from the SAM donor is visualized by autoradiography.
(C) Purification scheme for H3K9me1 KMT activity from HeLa S100 cytoplasmic extracts.
(D) Silver-stained SDS gel of active fractions after the last gel filtration column.
(E) KMT activity assay of these fractions on H3 (6–11) peptides, either unmodified (TARKST-2b) or H3K9me1 (TARK(me1)ST-2b). Incorporation of the radioactive
methyl group from the SAM donor is visualized by autoradiography. See also Figure S1 and Table S1.(i.e., PRDM16, ESET/SETDB1, SETD5, and ASH1L) of the
identified proteins contain the conspicuous SET domain, the
hallmark of most KMTs (Figure 2A), and therefore represented
strong candidates for H3K9me1 KMTs. In addition, we also
noticed the arginine methyltransferase PRMT5 as a prominent
hit among the identified peptide fragments. Because PRMT5950 Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc.has been described to modify histone H3 on arginine 8 (H3R8)
(Pal et al., 2004), our assay design using the short H3 peptides
(aa 6–11) might also select for such an activity. Although this is
indeed the case (Figure S1A), our subsequent analysis using
Prmt5 knockdown in iMEFs did not indicate a role for this
enzyme in heterochromatin formation (Figure S1B).
Prdm3 and Prdm16 Specifically Convert H3K9 to
H3K9me1 In Vitro
For the subsequent study, we focused our analysis on themouse
orthologs of the four identified SET domain proteins, PRDM16,
ESET, ASH1L, and SETD5. Although Eset has been previously
reported to mediate H3K9me1 and H3K9me3 (Loyola et al.,
2009; Wang et al., 2003), mammalian Ash1L had only been
described to target H3K4 and H3K36 (An et al., 2011; Gregory
et al., 2007). Setd5 and Prdm16 had not been shown to display
KMT activity. To examine the activity and specificity of these
potential H3K9me1 KMTs, bacterially or baculovirus expressed
proteins were incubated with recombinant H3 and cold SAM,
and the induced methylation status was probed with modifica-
tion-specific antibodies against H3K9 and H3K27 methylation.
Due to its close homology with Prdm16 (domain structure in
Figure 2A, 54% identity in the amino acid sequence), we also
included Prdm3 in this analysis. All examined proteins display
specificity toward the H3K9 position and do not methylate
H3K27 (Figure 2B), even though these two lysines reside in
a very similar sequence context (ARKS motif). Prdm3, Prdm16,
Setd5, and Ash1L act as H3K9me1 mono-KMTs in this assay
because they induce H3K9me1 but do not generate H3K9me3.
In line with previous reports (Loyola et al., 2009; Wang et al.,
2003), histones that were incubated with baculovirus expressed
Eset are recognized by H3K9me1 and H3K9me3 antibodies,
showing that this KMT is not an exclusivemono-KMT (Figure 2B).
Because Ash1L exhibited only very weak activity toward
H3K9me1 and had been described to be involved in active tran-
scription (Gregory et al., 2007), and Setd5 knockdown in iMEFs
did not affect heterochromatin integrity (data not shown), we
decided to focus our further analysis on Prdm3 and Prdm16 as
H3K9me1 KMTs.
We next sought to validate the specificity of Prdm3 and
Prdm16 toward H3K9me1 by an antibody-independent method.
For this, the reaction products of short linear H3 (aa 6–11)
peptides that had been incubated with recombinant Prdm3 or
Prdm16 were analyzed by MS. When an unmodified peptide
was used as substrate, Prdm3 and Prdm16 exclusively generate
monomethylation, with conversion rates ranging from 15.6% for
Prdm16 to 20.9% for Prdm3 (Figure 2C). The observed shift in
the corresponding mass spectra confirms the addition of only
one methyl-group (Figure 2C). The subsequent MS/MS analysis
proved that it is lysine 9 that is methylated (see Table S2).
Importantly, theH3K9me1peptide cannot be used as a substrate
by the Prdm3 or Prdm16 enzymes (Figure 2C). Taken together,
these data demonstrate that Prdm3 and Prdm16 act as
H3K9me1-specific KMTs in vitro.
Simultaneous Depletion of Prdm3 and Prdm16
Abrogates Pericentric H3K9me3 and H3K9me1
To address the role of Prdm 3 and Prdm16 for H3K9me1 in vivo,
we generated lentiviral shRNA constructs to knock down
their expression in immortalized mouse embryonic fibroblasts
(iMEFs). As a control, we also included the previously described
Eset/Setdb1 in this analysis. Multiple sequences for each mRNA
sequence were screened, and the most effective shRNA was
chosen for virus production (Figure S2). Interestingly, one of
the shRNAs designed for Prdm16 also targeted Prdm3, therebyallowing for an effective double knockdown using a single
shRNA construct (sh16/3; Figures S2B and S2C). We first per-
formed knockdowns in WT iMEFs, which display an accumula-
tion of H3K9me3 at DAPI-dense foci and a broad nuclear staining
of H3K9me1. Time points were taken at day 3, 6, and 12 after
infection and indirect immunofluorescence (IF) with H3K9methyl
antibodies was carried out. Single knockdown of Eset, Prdm3,
or Prdm16 did not result in a detectable alteration as compared
to control cells (scrambled shRNA) (Figure 3A). By contrast,
double knockdown of Prdm3 and Prdm16 abolished the pericen-
tric localization of H3K9me3 in more than 50% of the cells
(Figure 3A).
We next infected Suv39h dn iMEFs with the lentiviral shRNA
constructs. In Suv39h dn cells, H3K9me3 is lost from DAPI-
dense foci, which instead accumulate H3K9me1 (Peters et al.,
2003) (Figure 3B). Therefore, these cells provide an ideal
resource to directly examine dependence of pericentric
H3K9me1 on Prdm3, Prdm16, or Eset enzymes. IF analysis
with H3K9me1-specific antibodies revealed that simultaneous
depletion of Prdm3 and Prdm16 significantly disperses pericen-
tric H3K9me1 (ranging from 70% of cells at day 3 to 94% of cells
at day 12), whereas single knockdowns of Prdm3 and Prdm16
have no effect (Figure 3B). Depletion of Eset in Suv39h dn iMEFs
also interferes with pericentric H3K9me1 accumulation because
only 50%–33% of the cells maintain a focal enrichment for
H3K9me1 (Figure 3B). This result indicates that Eset contributes
to H3K9me1 at pericentric heterochromatin in Suv39h dn cells.
Importantly, our data reveal that Prdm3 and Prdm16 are redun-
dant H3K9me1 KMTs and specify a sequential pathway, in which
Prdm3/Prdm16-dependent H3K9me1 is important for the
subsequent conversion to H3K9me3 at pericentric heterochro-
matin by the Suv39h enzymes.
In addition to the H3K9me1 and H3K9me3 marks, we
also examined other histone modifications (H3K27me1 and
H4K20me3), DNA methylation (5-methylcytosine, 5-meC) and
chromatin-associated factors (e.g., HP1a) of pericentric hetero-
chromatin. For all these marks and factors, there is significant
dispersion from pericentric heterochromatin in Prdm3/Prdm16-
depleted iMEFs (Figure S3A). Further, and as already described
for the absence of the Suv39h enzymes (Martens et al., 2005),
there is pronounced loss of silencing of major satellite (major
sat) transcription in Prdm3/Prdm16-deficient WT and Suv39h
dn iMEFs (Figure S3B). Enhanced derepression ofmajor sat tran-
scription is also observed upon depletion of Eset in Suv39h dn
iMEFs, but not in WT iMEFs (Figure S3B).
With all these defects in heterochromatin definition, it is not
surprising that Prdm3/Prdm16-depleted iMEFs show progres-
sive impairment of cell viability both in WT and, even more
evident, in Suv39h dn cells. This is not a consequence of cell
death/apoptosis because there are less than 1% of WT or
Suv39h dn iMEFs that are positive for cleaved caspase 3
(data not shown). Examination of cell-cycle progression by
50-Bromo-20-Deoxyuridine (BrdU) incorporation indicates that
replication has largely stopped by day 6 after infection (Fig-
ure S4A), with a significant number of WT iMEFs staining positive
for the senescence marker b-Galactosidase (Figure S4B).
Consistent with similar observations (Reimann et al., 2010),
Suv39h dn iMEFs lack cellular senescence and do not displayCell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc. 951
AC
B
Figure 2. Prdm3 and Prdm16 Convert H3K9 to H3K9me1 In Vitro
(A) Domain structure of candidate H3K9me1 KMTs identified by MS. The PR-SET and SET domain are highlighted in light red, pre- and post-SET domain in dark
red, Zn-fingers (Zn-F) in light gray, Tudor domain and PhD fingers in dark gray, Bromo domain andmethyl-binding domain (MBD) in green. Blue arrows demarcate
the protein portions that were used as recombinant enzymes in KMT assays described below.
(B) KMT activity assay with candidate H3K9me1 methyltransferases. Recombinant enzymes were incubated with cold SAM and full-length histone H3. Induced
methylation states are visualized by western blot analysis with modification-specific antibodies directed against H3K9me1, H3K9me2, H3K9m3 and H3K27me1,
H3K27me2, and H3K27me3.
(C) MS analysis of Prdm3 and Prdm16 activity. Recombinant enzymes were incubated with cold SAM and linear H3 (aa 6–11) peptides, unmodified (TARKST),
or H3K9me1 (TARK(me1)ST). Reaction products were purified by nanoHPLC and then analyzed by MS. HPLC peaks are shown for both substrates. For
better illustration, HPLC peaks corresponding to unmodified (red) and H3K9me1 (blue) peptides were separated, as indicated by the color-coded x axes
below. For the unmodified peptide the corresponding mass spectra are included, demonstrating a shift in mass by 14 Da. See also Figure S1 and Tables S1
and S2.
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Figure 3. Simultaneous Depletion of Prdm3 and Prdm16 Abrogates
Pericentric H3K9me3 and H3K9me1
(A) Immunofluorescence analysis for H3K9me3 in WT iMEFs upon shRNA
mediated knockdown of Eset, Prdm3, Prdm16, and double knockdown of
Prdm3/Prdm16. Representative images at days 3, 6, and 12 after shRNA
transduction are shown. Percentages indicate cells that display the depicted
phenotype.
(B) Immunofluorescence analysis for H3K9me1 in Suv39h dn iMEFs upon
shRNA mediated knockdown of Eset, Prdm3, Prdm16, and double knock-
down of Prdm3/Prdm16. Representative images at days 3, 6, and 12 after
shRNA transduction are shown. Percentages indicate cells that display the
depicted phenotype.
See also Figures S2, S3, and S4.b-Galactosidase signals. However, Prdm3/Prdm16 depletion in
Suv39h dn iMEFs results in acute reduction of the overall cell
numbers, indicating that the combined absence of H3K9me1
(Prdm3/Prdm16) and H3K9me3 (Suv39h1 and Suv39h2) methyl-
ation systems defies cellular viability.
Prdm3 and Prdm16 Primarily Regulate H3K9me1
in the Cytoplasm
Our purification of the PRMD16 KMT from cytoplasmic extracts
strongly suggests that this (and the closely related PRDM3)
enzyme mediates H3K9me1 in a nonnucleosomal context.
However, the observed defects for H3K9me1 and H3K9me3
localization at pericentric heterochromatin upon Prdm3/
Prdm16-depletion occur in the nucleus. Isolation of acid-ex-
tracted histones from the cytoplasm and nucleus indicates
specific reduction of cytoplasmic, but not nuclear, H3K9me1
levels in Prdm3/Prdm16-deficient iMEFs (Figure 4A). We did not
detect changes in the abundance of cytoplasmic H3K9me2, nor
of bulk nuclear H3K9me1, H3K9me2, and H3K9me3. Although
Eset has also been implicated as a H3K9me1 KMT (Loyola
et al., 2009), our Eset knockdown conditions did not result
in any apparent alterations of either cytoplasmic or nuclear
H3K9 methylation levels (Figure 4A). To address modulation of
H3K9me1 and H3K9me3 at the major sat repeat sequences,
we next performed directed chromatin immunoprecipitation
(ChIP) in WT and Suv39h dn iMEFs that had been depleted
for Prdm3/Prdm16 or for Eset. Although there is a similar, yet
modest, decline for pericentric H3K9me1 signals in Suv39h dn
cells, major sat H3K9me3 levels in WT iMEFs are considerably
more reduced upon Prdm3/Prdm16 knockdown as compared
to Eset depletion (Figure 4B).
These data might imply that the Prdm3 and Prdm16 enzymes
could also directly reside at pericentric heterochromatin.
Because robust antibodies for ChIP analysis of endogenous
Prdm3 and Prdm16 are lacking (and our attempts to generate
custom-made antibodies failed), we generated iMEF cell lines
that stably express either 3xFLAG-HA-tagged Prdm3 (Prdm3-
F/H) or Prdm16 (Prdm16-F/H) (Figures S5A and S5B). We also
established a third cell line that gives rise to a deletion mutant
lacking the PR-SET domain of Prdm16 (Prdm16DPR-F/H).
Although this mutant is significantly less active, immunoprecipi-
tated Prdm16DPR-F/H is still able to methylate an unmodified
H3 peptide (Figure S5C), probably because of interaction with
endogenous Prdm16 and/or Prdm3. We therefore did not
include this mutant in the subsequent ChIP experiments.
To analyze chromatin association of the ectopic Prdm3-F/H
and Prdm16-F/H enzymes (using a combination of a-FLAG and
a-HA antibodies), we performed directed ChIP for the major
sat repeats and, as controls, also for two described Prdm3 target
genes (Gadd45g, Dcn) and at one nontarget gene (Plagl1)
(Yatsula et al., 2005). Although both Prdm3-F/H and Prdm16-
F/H accumulate at the Gadd45g and Dcn promoters, they are
not enriched at the major sat repeats (Figure 4C). Moreover,
H3K9me1 and H3K9me3 signals at the Gadd45g and Dcn target
regions are unaltered in Prdm3-F/H or Prdm16-F/H iMEFs
as compared to WT controls, and chromatin association of
Prdm3-F/H and Prdm16-F/H does not appear to correlate with
increased H3K9me1 (or H3K9me3) levels (Figure 4C). This isCell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc. 953
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Figure 4. Prdm3 and Prdm16 Primarily Regulate H3K9me1 in the Cytoplasm
(A) Western blot analysis of H3K9 methylation states in cytoplasmic and nuclear extracts of WT and Suv39h dn iMEFs upon Eset and Prdm3/Prdm16 double
knockdown. Acid-extracted histones were probed with modification-specific antibodies for unmodified H3, H3K9me1, H3K9me2, and H3K9me3. Antibodies
against Gapdh (cytoplasmic) and HP1a (nuclear) were used as fractionation controls.
(B) Histogram for ChIP analysis of major sat repeats in WT and Suv39h dn iMEFs upon Eset and Prdm3/Prdm16 double knockdown with antibodies directed
against H3K9me1 and H3K9me3. Error bars represent SD.
(C) Histogram for ChIP analysis of 3xFLAG-HA-tagged Prdm3 and Prdm16 in WT iMEFs. Occupancy of the ectopic proteins was analyzed at major sat repeats,
two described Prdm3 targets (Gadd45g, Dcn) and one Prdm3 nontarget (Plagl1). In addition, methylation levels at these regions were probed with H3K9me1 and
H3K9me3 antibodies. Error bars represent SD.
See also Figure S5.a surprising result, suggesting that Prdm3 and Prdm16 either
cannot modify nucleosomes or that the nucleosomal H3K9
position is not an available substrate. The functions of Prdm3
and Prdm16 at the Gadd45g and Dcn (and other) target
promoters will probably involve activities that are distinct from
methylating free histone H3. Taken together, these collective
data exclude a direct localization of the Prdm3 and Prdm16 at
pericentric heterochromatin, but are consistent with an indirect
mechanism that involves a deposition-based model for Prdm3/
Prdm16-dependent H3K9me1 of free histone H3 in the cyto-954 Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc.plasm and its subsequent nuclear incorporation into pericentric
heterochromatin.
Impaired Prdm3/Prdm16 Function Disintegrates
Heterochromatic Foci and Breaks Heterochromatin
Organization
We noticed from the above IF analyses (Figure 3 and Figure S3A)
that Prdm3/Prdm16 knockdown reproducibly induces diffuse
DAPI staining and, in extreme cases, even dissolves DAPI-dense
foci that are formed by the clustering of the A/T-rich major sat
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Figure 5. Impaired Prdm3/Prdm16 Function Disintegrates Hetero-
chromatic Foci
DNA-FISH for major sat repeats in WT and Suv39h dn iMEFs upon Eset and
Prdm3/Prdm16 double knockdown. Representative images at day 3 after
shRNA transduction are shown. Percentages indicate cells that display the
depicted phenotype. See also Figures S6 and S7.repeats. To directly analyze the organization of DAPI-dense
heterochromatic foci, we performed DNA-FISH with probes
that are specific for the major sat repeats. In control cells treated
with scrambled shRNA, the DNA-FISH signal for major sat
repeats perfectly overlaps with DAPI-dense focal staining, both
inWT andSuv39h dn iMEFs (Figure 5, top). This finding illustrates
that loss of pericentric H3K9me3 (and H4K20me3 and HP1a) inSuv39h dn cells is not sufficient to alter heterochromatic DNA
organization. Similarly, knockdown of Eset in WT cells did not
significantly affect the focal arrangement of major sat repeats,
whereas the DNA-FISH signals appear more decondensed in
Suv39h dn iMEFs (Figure 5, bottom). This result suggests
a possible compensation by the Eset enzyme in protecting the
heterochromatic structure, if it still contains H3K9me1. By
contrast, simultaneous depletion of Prdm3 and Prdm16 leads
to a dramatic impairment of major sat organization: the focal
accumulation is entirely abolished and the remaining DNA-
FISH signals resemble a network of disentangled chromatin
fibers (Figure 5, middle). This collapse is more pronounced in
Suv39h dn (observed in 82% of cells) as compared to WT iMEFs
(observed in 48% of cells). The massive dissolution of hetero-
chromatic foci in Prdm3/Prdm16 iMEFs represents the most
dramatic breakdown for heterochromatin organization and
significantly exceeds heterochromatic defects, as they are
described for Suv39h dn cells (Peters et al., 2003; Peters et al.,
2001), Suv4-20h dn cells (Schotta et al., 2008), Eset knockdown
cells (see Figure 5), Dnmt3a/Dnmt3b dn cells (Lehnertz
et al., 2003; Okano et al., 1999), and Pax3/Pax9 deficient cells
(Karslioglu et al., 2012).
To exclude any off-target effects and to validate this central
result, we depleted Prdm3 and Prdm16 by the combined trans-
duction of shRNAs (shPrdm3 + shPrdm16, each with different
sequence selectivity as compared to the double-knockdown
sh16/3 lentivirus; Figures S2B and S2C) in WT and Suv39h dn
iMEFs, which recapitulates disintegration of heterochromatic
foci (Figure S6). In addition, we also derived Prdm3 null (Goyama
et al., 2008) and Prdm16-deficient iMEFs from mutant mice. IF
for H3K9me3 and DNA-FISH indicates that 35% of Prdm3 null
iMEFs display dissolved heterochromatic clusters (Figure S7),
whereas Prdm16-deficient cells appear normal for heterochro-
matin organization but show aberrant staining for Lamin A/C in
the nuclear periphery (see below).
Depletion of Prdm3/Prdm16 Also Unstructures
the Nuclear Lamina
Considering the severe defects in cell viability (see above) upon
simultaneous depletion of Prdm3 and Prdm16, we wanted to
exclude that the disintegration of heterochromatin is due to an
overall breakdown of nuclear integrity. We therefore analyzed
other prominent nuclear structures, such as nucleoli and the
nuclear lamina. Nucleoli are a particularly good control because
they display a distinct subnuclear localization, contain repeated
DNA sequences (the rRNA gene clusters), and accumulate
condensed chromatin (McStay and Grummt, 2008; Ne´meth
and La¨ngst, 2011). IF for the nucleolar marker Fibrillarin
shows that the nucleolar structure is not altered upon simulta-
neous depletion of Prdm3/Prdm16 in WT iMEFs (Figure 6A).
Although WT cells contain around four to five large nucleoli,
Suv39h dn iMEFs have, on average, 12 smaller Fibrillarin-posi-
tive foci (Figure 6A). This is consistent with previous analyses
in Drosophila that implicate SU(VAR)3-9 in determining nucleoli
numbers (Peng and Karpen, 2007). Despite this difference,
Prdm3/Prdm16 double knockdown did not further affect
Fibrillarin localization or nucleolar definition in WT or Suv39h
dn iMEFs.Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc. 955
A DAPI Lamin A/C
B
sc
ra
m
bl
ed
 s
hR
N
A
Pr
dm
3/
Pr
dm
16
 k
d
sc
ra
m
bl
ed
 s
hR
N
A
Pr
dm
3/
Pr
dm
16
 k
d
w
ild
-ty
pe
 iM
EF
s
Su
v3
9h
 d
n 
iM
EF
s
FibrillarinDAPI
5
61%
81%
12
12
83%
37%
sc
ra
m
bl
ed
 
sh
R
N
A
Pr
dm
3/
Pr
dm
16
 k
d
electron 
microscopy Lamin A/C
sc
ra
m
bl
ed
 
sh
R
N
A
Pr
dm
3/
Pr
dm
16
 k
d
w
t i
M
EF
s
Su
v3
9h
 d
n 
iM
EF
s
4
3D reconstruction
Figure 6. Depletion of Prdm3/Prdm16 Unstructures the Nuclear
Lamina
(A) Immunofluorescence analysis for marker proteins of nucleoli (Fibrillarin) and
the nuclear lamina (Lamin A/C) in WT and Suv39h dn iMEFs upon double
knockdown of Prdm3/Prdm16. Representative images at day 3 after shRNA
transduction are shown. Numbers in the left panels represent number of
nucleoli and percentages in the right panels indicate cells that display the
depicted phenotype.
(B) EM images and 3D reconstructions of one representative cell for either WT
and Suv39h dn iMEFs upon control and Prdm3/Prdm16 double knockdown.
Three serial sections are displayed for each cell. Heterochromatic regions are
highlighted in green, the nuclear lamina is depicted in blue and invaginations of
the nuclear membrane are shown in purple. In addition, Lamin A/C stainings
are included.We next examined the nuclear lamina because this structure
has been described to interact withmammalian heterochromatin
(Kind and van Steensel, 2010; Towbin et al., 2009). HP1 proteins
have been shown to directly bind to the Lamin B receptor, which
could provide a mechanism to anchor pericentric heterochro-
matin at the nuclear periphery (Ye et al., 1997). To analyze the
integrity of the nuclear lamina upon Prdm3/Prdm16 double956 Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc.knockdown, we stained WT and Suv39h dn iMEFs for Lamin
A/C at day 3 after shRNA infection. In control (scrambled shRNA)
iMEFs, Lamin A/C localizes to the nuclear envelope with a ring-
like staining in WT and a more diffuse, yet rim-associated distri-
bution, in Suv39h dn cells (Figure 6A). By contrast, depletion of
Prdm3/Prdm16 results in an aberrant pattern of the Lamin A/C
signals in WT and Suv39h dn cells. Although there are more
affected cells in WT iMEFs (81%) as compared to Suv39h dn
iMEFs (37%), Prdm3/Prdm16-depletion in Suv39h dn iMEFs
results in a more pronounced unstructuring of the nuclear
lamina. The laminar proteins are no longer aligned along the
nuclear envelope but fuse into disordered patches at the nuclear
rim and within the nucleus (Figure 6A).
To analyze the dissolved heterochromatin and perturbed
nuclear lamina at higher resolution, we conducted serial block-
face scanning electron miscrocopy (SBFSEM) (Denk and Horst-
mann, 2004) of control and Prdm3/Prdm16 knockdown iMEFs
(see Experimental Procedures). We then used the entire stack
of SBFSEM images to reconstruct the 3D architecture of
selected nuclei (Figure 6B). For these 3D reconstructions we
focused on heterochromatic foci (shown in green) and the
nuclear lamina (depicted in blue). In each image, the outline/
contour of the nuclear lamina and of the heterochromatic foci
was manually demarcated and these highlighted sections were
then processed for a 3D reconstruction using Neurolucida soft-
ware (see Experimental Procedures). This high-resolution EM
analysis illustrates the significant disintegration of heterochro-
matin and concurrent defects in nuclear lamina organization in
Prdm3/Prdm16 knockdown cells (Figure 6B). In addition, the
invaginations of the nuclear envelope, (highlighted in purple)
are particularly evident and appear more pronounced upon
depletion of Prdm3 and Prdm16 in Suv39h dn iMEFs.
DISCUSSION
The Prdm3 and Prdm16 H3K9me1 Methyltransferases
Are Multifunctional Factors
Our study identifies Prdm3 and Prdm16 as H3K9me1 KMTs that
safeguard heterochromatin structure and organization. Both
enzymes are members of the Prdm protein family, which is char-
acterized by the combination of a PR-SET domain with a variable
number of Zn-fingers (Fumasoni et al., 2007) (see Figure 2A). The
PR-SET module is related to the classical SET domain and
contains all critical residues required for KMT activity (Huang,
2002). Thus, this unique combination of a catalytic domain with
DNA-recognition motifs predicts (at least) a dual role for Prdm
proteins: as histone-modifying enzymes (mediated via the
PR-SET domain) and as bona-fide transcription factors (via the
Zn-fingers). Moreover, our data show that Prdm3 and Prdm16
work as cytoplasmic enzymes to direct H3K9me1 on free histone
H3 (Figures 2 and 4), are present in the nucleus at described
target gene loci (but not at pericentric heterochromatin) (Fig-
ure 4), and are essential to maintain heterochromatin clustering
(Figure 5) and the structure of the nuclear lamina (Figure 6). It is
unlikely that all of these functions are solely mediated by their
H3K9me1 activity. This is particularly evident because chromatin
association of Prdm3 and Prdm16 does not directly correlate
with increased H3K9me1 (and H3K9me3) at their target genes
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Figure 7. Deposition-Based Model for the Initiation and Maintenance of Mammalian Heterochromatin
InWT iMEFs, Prdm3 and Prdm16 direct H3K9me1 of cytoplasmic histone H3, which is then transported to the nucleus and incorporated into nucleosomes where
it is converted by the Suv39h enzymes to H3K9me3 at heterochromatic foci (blue dots) that correspond to clusters of major satellite repeats. Upon Prdm3/
Prmd16-depletion, cytoplasmic H3K9me1 is diminished, leading to insufficient generation of pericentric H3K9me3 by the Suv39h enzymes. In addition to the
reduction of H3K9me1 (and H3K9me3) at pericentric heterochromatin, impaired Prdm3/Prdm16 function also results in the collapse of the major satellite repeat
clusters (blue fibers) and breaks a proposed anchor in the nuclear lamina, which becomes unstructured (disorganized black outline). This model predicts the
Prdm3 and Prdm16 KMTs as multi-functional enzymes with substrates that are not restricted to histone H3. See text for detailed explanation.(Figure 4) and because Prdm3/Prdm16-dependent defects in the
nuclear lamina appear to require other modes in addition to per-
turbedH3K9me1 localization (see below). Thus, as is the case for
many KMTs (Huang and Berger, 2008; Lan and Shi, 2009), the
spectrum of possible substrates for Prdm3 and Prdm16 will,
almost certainly, not be restricted to histone H3.
Whereas Prdm proteins are well conserved among verte-
brates, there are significantly less Prdm family members in inver-
tebrates (Fumasoni et al., 2007). For example, the Drosophila
genome contains only three and the Caenorhabditis elegans
genome only two annotated Prdm genes. Notably, there are
no proteins that combine a SET domain with Zn-fingers in
unicellular organisms such as Saccharomyces cerevisiae and
Schizosaccharomyces pombe (Fumasoni et al., 2007). To
address an evolutionarily conserved function for Prdm proteins
in heterochromatin maintenance, hamlet, the closest ortholog
toPrdm3 andPrdm16 genes inDrosophila, is currently examined
in PEV models to reveal a predicted Su(var) phenotype (collabo-
ration with G. Reuter, Martin Luther University Halle-Wittenberg,
Germany). However, there is no clear ortholog for Prdm3/
Prmd16 in C. elegans, where H3K9me1 and H3K9me2 appear
to be mediated by the Eset/Setdb1-related enzyme MET-2
(Towbin et al., 2012, this issue of Cell).
A Deposition-Based Pathway for H3K9me1
at Mammalian Heterochromatin
Our analysis of the redundant H3K9me1 KMTs Prdm3 and
Prdm16 suggests a deposition-based pathway for the accumu-
lation of H3K9me1 (and H3K9me3) at mammalian heterochro-
matin (see model, Figure 7): the Prdm3 and Prdm16 enzymes
catalyze H3K9me1 on free histone H3 in the cytoplasm, which
is then transported into the nucleus, incorporated at pericentric
heterochromatin and converted to H3K9me3 by the chromatin-
associated Suv39h enzymes. This pathway is supported by the
reduction of cytoplasmic H3K9me1 levels in Prdm3/Prdm16-
depleted cells (Figure 4) and the dispersion (Figure 3) anddecreased occurrence (Figure 4B) of H3K9me1 and H3K9me3
signals at pericentric heterochromatin. A deposition-based
mechanism is further indicated by the absence of ectopic
Prdm3 and Prdm16 at major sat sequences (Figure 4C). For
H3K9me3, the sequence of step-wise methylation seems to be
conserved in C. elegans, where H3K9me1/H3K9me2 by MET-2
is a prerequisite for the subsequent trimethylation by SET-25,
a Suv39h-like enzyme (Towbin et al., 2012, this issue of Cell).
Previous studies have involved other H3K9-specific enzymatic
complexes at pericentric heterochromatin, such as the replica-
tion-coupled ESET/HP1a/CAF1 complex (Loyola et al., 2009)
or a substochiometric G9A/GLP1/ESET/SUV39H1 complex
(Fritsch et al., 2010). Eset/Setdb1 was also identified in our
biochemical purification and our knockdown analysis for Eset
indicates a functional connection with the Suv39h enzymes
because we observe a significant upregulation of major sat
transcription (Figure S3B) and partial decondensation of hetero-
chromatic foci in Suv39h dn iMEFs (Figure 5). The mechanistic
details of this interaction require further analysis, but it is possible
that the Eset/HP1a/Caf1 complex, which mainly processes
H3K9me1 (Loyola et al., 2009), could also facilitate incorporation
of Prdm3/Prdm16-mediated H3K9me1 during chromatin repli-
cation. Intriguingly, the majority of peptide fragments that were
co-purified with the cytoplasmic H3K9me1 activity (Figure 1D)
reveal the presence of components of the replication machinery
and of protein chaperones (see Table S1).
In addition to the crucial function of H3K9me1, we have previ-
ously described another monomethylation state, H3K27me1, to
be enriched at pericentric heterochromatin (Peters et al., 2003).
This modification is independent of the Suv39h-HP1 system
because it accumulates at DAPI-dense foci in both WT and
Suv39h dn iMEFs (Figure S3A). The responsible H3K27me1
KMT has not yet been identified, although a recent report has
shown a modest reduction for H3K27me1 levels in G9a-null ES
cells (Wu et al., 2011). It would not be inconsistent with our
data for Prdm3/Prdm16 in directing H3K9me1 that such anCell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc. 957
activity could be promoted by another Prdm enzyme. This is an
intriguing possibility becausewe observe that truncated versions
of Prdm16 that lack several Zn-fingers change its target speci-
ficity and are also capable of catalyzing H3K27me1 instead
of H3K9me1 (data not shown). This finding suggests that the
Zn-fingers of Prdm16 may contribute to an allosteric regulation
of enzyme activity. The accumulation of H3K27me1 at hetero-
chromatin is conserved in Arabidopsis and the loss of the
H3K27me1-specific enzymes ATXR5 and ATXR6 results in
partial decondensation of chromocenters (Jacob et al., 2009).
Prdm3/Prdm16 and the Nuclear Lamina
Simultaneous depletion of Prdm3 and Prdm16 causes the most
severe dissolution of heterochromatin integrity (Figures 5 and
6B). Strikingly, this breakdown of heterochromatic foci corre-
lates with concurrent defects in the structuring of the nuclear
lamina (see model in Figure 7). In WT cells, heterochromatic
anchoring could be provided by H3K9me3, HP1a or Suv39h,
all of which concentrate at DAPI-dense foci. However, loss of
Suv39h enzymes alone does not impair the structure of hetero-
chromatin or the nuclear lamina (Figure 5, top, and Figure 6B).
Because pericentric H3K9me3 is reduced to H3K9me1 in
Suv39h dn cells, it is unlikely that H3K9me3 constitutes the
sole heterochromatin anchor. Despite its weak affinity toward
H3K9me1 (Fischle et al., 2003), HP1a might still contribute to
attachment of heterochromatin to the nuclear lamina, particularly
because it has been shown to bind the Lamin B receptor (Ye
et al., 1997). Our data on the absence of pericentric localization
of Prdm3 and Prdm16 (Figure 4C) largely exclude these enzymes
or a specific Prdm3/Prdm16-containing protein complex for
a direct interaction with a component of the nuclear lamina.
Moreover, the functional studies on heterochromatin anchoring
in mammalian cells (this work) or in C. elegans (Towbin et al.,
2012, this issue of Cell) have identified different KMTs (Prdm3/
Prdm16 versus MET-2/SET-25) that share similar activities
(e.g., H3K9me1 methylation) but otherwise lack a comparable
domain composition of the respective enzymes. We therefore
propose that it is the intrinsic lysine monomethylation activity
of Prdm3/Prdm16 toward H3K9 and a currently unknown chro-
matin factor or a nuclear lamina component that might be
required for the structural integrity of mammalian heterochro-
matin. Such a nonhistone substrate would be predicted to
contain the –ARKS– or a closely related target motif. Conspicu-
ously, interrogation of the amino acid sequences of described
laminar-associated components revealed the Lamin B receptor
(QRKS motif) and Lamin B2 (ARKS motif) as potential substrates
to be methylated by Prdm3/Prdm16. For future studies, it will be
critical to dissect whether the nuclear lamina defect is
a consequence of heterochromatin breakdown or caused by
the impaired function of a laminar component that needs to be
methylated by Prdm3 and Prdm16. Notably, interference of
H3K9 methylation by the HDAC-inhibitor trichostatin A (TSA)
(Taddei et al., 2001) results in dispersion of pericentric
H3K9me1 and H3K9me3 localization and also partly dissolves
the focal organization of major sat repeat clusters but does not
unstructure the nuclear lamina (data not shown). Although the
underlying molecular pathways connecting H3K9me1 deposi-
tion and heterochromatin anchoring remain to be further defined,958 Cell 150, 948–960, August 31, 2012 ª2012 Elsevier Inc.our discovery of the Prdm3/Prdm16 KMTs exposes these
enzymes and the H3K9me1 mark as important components
to initiate and secure the structural integrity of mammalian
heterochromatin.
EXPERIMENTAL PROCEDURES
Fractionation of Cells and Acid Extraction of Histones
Cytoplasmic and nuclear extracts of HeLa cells and mouse fibroblasts were
prepared according to standard protocols (Dignam et al., 1983). Fractionation
efficiency was controlled by western blotting for Gapdh and HP1a. Histones
were acid-extracted and cytoplasmic histones were further concentrated by
using 10k Amicon Ultra centrifugal devices (Millipore).
Histone Methyltransferase Assays
Radioactive KMT assays were conducted as described (Nishioka et al., 2002;
Schotta et al., 2004). In a typical reaction, 1 mg of full-length recombinant
histone H3 (New England Biolabs) or 800 mM of histone peptides were
incubated with 1 mCi of s-Adenosyl-L-(methyl-3H)methionine (Perkin Elmer).
As source of enzymatic activity, we used 2 to 5 ml cytoplasmic and
nuclear extracts or immunoprecipitated enzymes (PRMT5-F, Prdm3-F/H,
Prdm16-F/H, and Prdm16DPR-F/H). A detailed protocol for immunoprecipita-
tion of ectopic proteins is provided in the Extended Experimental Procedures.
For nonradioactive KMT assays, 0.2–1 mg of purified enzyme and 20 mM of
s-Adenosyl-L-methionine (New England Biolabs) were used in a reaction
mixture as described above. The reaction products were examined bywestern
blotting with modification-specific antibodies for H3K9 and H3K27. Antibodies
are listed in Table S3.
Biochemical Purification of H3K9me1 KMTs
HeLa S100 cytoplasmic fractions were prepared as previously described
(LeRoy et al., 1998). Twelve grams of cytoplasmic protein extract was loaded
on a series of chromatography columns and the H3K9me1 activity during the
purification was monitored via radioactive KMT assays on H3 peptides, either
unmodified (TARKST-2b) ormonomethylated (TARK(me1)ST-2b). After the last
sizing column, active fractions were loaded on a 10% polyacrylamide gel,
stained with silver nitrate and analyzed by MS. A detailed description of the
purification protocol including buffer composition is available in the Extended
Experimental Procedures.
Recombinant Expression of H3K9me1 KMTs
Bacterially expressed GST-tagged Prdm16, Prdm3, Setd5, and Ash1L were
purified with Glutathione Sepharose 4B resin (GE Healthcare) and eluted
with PreScission protease (GE Healthcare) according to the manufacturer’s
protocol (GE Healthcare). Sequences of pGex6P1 expression constructs are
available upon request. Eset was expressed in the Baculovirus expression
system according to standard protocols (Invitrogen). FLAG-tagged Eset was
purified with the M2 affinity gel (Sigma) and eluted with FLAG-peptide (Sigma)
according to manufacturer’s protocol (Sigma).
MS Analysis of In Vitro Methylation Products
In vitro methylation reactions with recombinant Prdm3 or Prdm16, cold SAM
and histone H3 peptides (TARKST or TARK(me1)ST; 5 mM concentration)
were analyzed by using nanoflow RPLC-MS on a LTQ-Orbitrap XL mass
spectrometer. Peptides were identified and quantified based on high-mass
accuracy/high-resolution Orbitrap FT-MS spectra. MS/MS fragmentation
spectra were recorded in order to prove lysine monomethylation. A detailed
description of mass spectrometric conditions and quantitative analysis is
presented in the Extended Experimental Procedures.
Production of shRNAs and Lentiviral Particles
The knockdown of Prdm16, Prdm3, Eset, and Prmt5 was done by using
shRNAs in a lentiviral system. Bacterial glycerol stocks of E. coli carrying the
lentiviral plasmids were purchased from Sigma (MISSION shRNA). Plasmid
DNA was transfected into 293FT cells for production of lentiviral particles
according to standard protocols (RNAi consortium, Broad Institute). A detailed
cloning protocol is described in the Extended Experimental Procedures.
shRNA sequences are listed in Table S4.
Immunofluorescence Staining
Wt and Suv39h dn iMEFs were plated on Lab-Tek II 8-well chamber slides
(Nunc) and infected with respective lentiviruses. One day after infection cells
were selected for puromycin resistance. Cells were fixed at days 3, 6, and
12 of knockdown with 4% paraformaldehyde and permeabilized with 0.2%
Triton X-100. Immunofluorescence was performed as described before
(Peters et al., 2003). Slides were evaluated in a Zeiss Axioimager Z.1 equipped
with Apotomeslider and a XBO 75 Watt fluorescence bulb. Images were
acquired with the 633 immersion objective and the Axiovision 4.82 software.
For quantifications, an average of 300 cells was counted per staining.
Cell Lines Expressing Ectopic Prdm3, Prdm16, and Prdm16DPR
Wt iMEFs were transfected with pCAGGS-plasmids containing Prdm3,
Prdm16, or Prdm16DPR with a C-terminal 3xFLAG-HA (F/H) tag under the
control of the chicken b-actin/rabbit b-globin hybrid promoter. An IRES fol-
lowed by a puromycin resistance cassette allowed for selection of stable cell
lines. Plasmid sequences are available upon request.
Chromatin Immunoprecipitation
ChIP was performed according to standard protocols (Martens et al., 2005).
For precipitation of F/H-tagged proteins, a mixture of anti-FLAG and anti-HA
antibodies was used. Antibodies and primers are listed in Tables S3 and S5.
DNA-FISH for Major Sat Repeats
Cells were fixed with 4%PFA, extractedwith 0.2% Triton X-100, and then sub-
jected to a standard DNA-FISH protocol using a mixture of four locked DNA
oligonucleotides that are complementary to the mouse major sat consensus
sequence. For quantifications, an average of 300 cells was counted per stain-
ing. Sequences of the locked nucleic acid probes are listed in Table S6.
Serial Block-Face Scanning Electron Microscopy
Wt and Suv39h dn iMEFs were seeded on Thermanox coverslips (Nunc) and
infected with the control and Prdm16/Prdm3 lentiviruses for knockdown. After
3 days of infection, cells were fixed, stained with uranyl acetate, processed
according to standard EM protocols (Rouquette et al., 2009), and finally
embedded in Epon resin. In order to observe the nuclei in 3D, serial block-
face scanning electron microscopy (SBFSEM) was performed as previously
described (Denk and Horstmann, 2004). A detailed staining and SBFSEM
protocol is available in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and six tables and can be found with this article online at http://dx.doi.
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